N-(2-mercaptoethyl)-1,3-propanediamine (WR-1065) protects thymocytes from programmed cell death.

Area of Science:

• Cell Biology
• Radiation Biology
• Biochemistry

Background:

• Thymocytes undergo apoptosis (programmed cell death) when exposed to gamma-irradiation, glucocorticoids, or calcium ionophores.
• This process involves DNA fragmentation mediated by a Ca(2+)- and Mg(2+)-dependent nuclear endonuclease.

Purpose of the Study:

• To investigate the protective effect of N-(2-mercaptoethyl)-1,3-propanediamine (WR-1065) against thymocyte apoptosis.
• To elucidate the mechanism by which WR-1065 inhibits radiation-induced and other forms of apoptosis.

Main Methods:

• Exposure of thymocytes to gamma-radiation, dexamethasone, or calcium ionophore A23187.
• Treatment of thymocytes with WR-1065 post-irradiation.
• Assay of DNA fragmentation and cell death.
• Incubation of isolated thymocyte nuclei with WR-1065 and assessment of endonuclease activity.

Main Results:

• WR-1065 effectively blocked DNA fragmentation and cell death in thymocytes induced by gamma-radiation, dexamethasone, and A23187.
• Post-irradiation incubation with WR-1065 conferred protection, but pre- or co-incubation did not.
• WR-1065 inhibited the Ca(2+)- and Mg(2+)-dependent DNA fragmentation in isolated thymocyte nuclei.

Conclusions:

• WR-1065 protects thymocytes from apoptosis by inhibiting the Ca(2+)- and Mg(2+)-dependent nuclear endonuclease.
• The timing of WR-1065 administration is crucial for its radioprotective effect.